News
In this video, Jay Chhablani, MD, discusses findings presented at the ARVO meeting from a phase 2b study evaluating suprachoroidal axitinib for neovascular age-related macular degeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback